Two Sigma Advisers
GRTX

Two Sigma Advisers’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Two Sigma Advisers’s Portfolio GRTX Stock Details GRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-12,700
Closed -$39.6K – 2626
2023
Q2 		$39.6K Sell
12,700
-400
-3% -$1.19K ﹤0.01% 2288
2023
Q1 		$33.5K Sell
13,100
-100
-0.8% -$206 ﹤0.01% 2482
2022
Q4 		$19.7K Sell
13,200
-900
-6% -$1.46K ﹤0.01% 2430
2022
Q3 		$25K Sell
14,100
-36,800
-72% -$52K ﹤0.01% 2432
2022
Q2 		$66K Sell
50,900
-99,200
-66% -$170K ﹤0.01% 2447
2022
Q1 		$357K Buy
150,100
+133,700
+815% +$348K ﹤0.01% 2149
2021
Q4 		$75K Buy
+16,400
New +$54.2K ﹤0.01% 2443

Other funds holding GRTX

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Two Sigma Advisers's GRTX Position: Q3 2023 in Review

Two Sigma Advisers sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q3 2023, closing a stake of 12,700 shares — an estimated $39.6K sold.

Two Sigma Advisers first reported a position in GRTX in Q4 2021 and held it in 7 quarters. The position peaked at $357K in Q1 2022. 38 funds tracked by Wall St. Rank hold GRTX as of Q3 2023.

  • Two Sigma Advisers reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Two Sigma Advisers sold 12,700 Galera Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $39.6K.
  • Two Sigma Advisers first reported a position in Galera Therapeutics, Inc. Common Stock in Q4 2021 and held it in 7 quarters.
  • Two Sigma Advisers's Galera Therapeutics, Inc. Common Stock position peaked at $357K in Q1 2022.
  • 38 funds tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Two Sigma Advisers's 13F filing for Q3 2023, filed 14 Nov 2023.